Skip to content

Innoviva, Inc. INVA Share Buybacks

Share Buybacks at other companies

Merck & Co. logo
Merck & Co.MRK
$874M-24.9%
AbbVie logo
AbbVieABBV
$1.49B+54.9%
Alkermes logo
AlkermesALKS
$27.7M
Royalty Pharma logo
Royalty PharmaRPRX
$50.1M-92.9%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$19.76M+97.5%
United Therapeutics logo
United TherapeuticsUTHR
$1.5B

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s share buybacks?
Innoviva, Inc. (INVA) reported share buybacks of $20.25M in Q1 2026.
What is the long-term trend for Innoviva, Inc.'s share buybacks?
Over 3 years (2021 to 2025), Innoviva, Inc.'s share buybacks has grown at a -77.4% compound annual growth rate (CAGR), from $394.15M to $4.53M.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.